Rare diseases
Investigational molecules
Locations
Back to Slovakia9 clinical trials in Humenne, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
SlovakiaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
SlovakiaStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
SlovakiaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
SlovakiaStudy on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
SlovakiaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on Chronic Obstructive Pulmonary Disease (COPD) are evaluating innovative treatments including tezepelumab and combination therapies to reduce disease exacerbations and improve patient outcomes.
Research emphasizes treatment efficacy in moderate to very severe cases.
Innovative research exploring bronchodilator combinations and novel therapeutic approaches for treating chronic respiratory conditions, with a focus on cardiopulmonary outcomes and disease management.
Studies aim to optimize treatment approaches for respiratory disorders.
Specialized trials investigating treatments for refractory and unexplained chronic cough, including the evaluation of BLU-5937 for cough frequency reduction in adult patients.
Research focuses on addressing persistent cough conditions resistant to standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
